- Home
- BQ vs BGLC Comparison
BQ vs BGLC Comparison
Compare BQ & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BQ
- BGLC
- Stock Information
- Founded
- BQ 2008
- BGLC 2017
- Country
- BQ China
- BGLC Malaysia
- Employees
- BQ N/A
- BGLC N/A
- Industry
- BQ Other Specialty Stores
- BGLC Medical Specialities
- Sector
- BQ Consumer Discretionary
- BGLC Health Care
- Exchange
- BQ Nasdaq
- BGLC Nasdaq
- Market Cap
- BQ 6.0M
- BGLC 5.8M
- IPO Year
- BQ 2020
- BGLC N/A
- Fundamental
- Price
- BQ $2.19
- BGLC $2.85
- Analyst Decision
- BQ
- BGLC
- Analyst Count
- BQ 0
- BGLC 0
- Target Price
- BQ N/A
- BGLC N/A
- AVG Volume (30 Days)
- BQ 78.8K
- BGLC 86.5K
- Earning Date
- BQ 05-27-2025
- BGLC 05-27-2025
- Dividend Yield
- BQ N/A
- BGLC N/A
- EPS Growth
- BQ N/A
- BGLC N/A
- EPS
- BQ N/A
- BGLC N/A
- Revenue
- BQ $81,208,354.00
- BGLC $9,265,870.00
- Revenue This Year
- BQ N/A
- BGLC N/A
- Revenue Next Year
- BQ N/A
- BGLC N/A
- P/E Ratio
- BQ N/A
- BGLC N/A
- Revenue Growth
- BQ N/A
- BGLC N/A
- 52 Week Low
- BQ $1.62
- BGLC $2.01
- 52 Week High
- BQ $7.40
- BGLC $8.40
- Technical
- Relative Strength Index (RSI)
- BQ 46.98
- BGLC 50.58
- Support Level
- BQ $1.85
- BGLC $2.85
- Resistance Level
- BQ $2.82
- BGLC $3.25
- Average True Range (ATR)
- BQ 0.26
- BGLC 0.26
- MACD
- BQ 0.02
- BGLC 0.03
- Stochastic Oscillator
- BQ 26.80
- BGLC 40.09
About BQ Boqii Holding Limited representing
Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.